Cargando…
HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors
Since the human immunodeficiency virus (HIV) was discovered as the etiological agent of acquired immunodeficiency syndrome (AIDS), it has encouraged much research into antiviral compounds. The reverse transcriptase (RT) of HIV has been a main target for antiviral drugs. However, all drugs developed...
Autores principales: | Beilhartz, Greg L., Götte, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185654/ https://www.ncbi.nlm.nih.gov/pubmed/21994660 http://dx.doi.org/10.3390/v2040900 |
Ejemplares similares
-
Inhibitors of HIV-1 Reverse Transcriptase—Associated Ribonuclease H Activity
por: Ilina, Tatiana, et al.
Publicado: (2012) -
The catalytic mechanism, metal dependence, substrate specificity, and biodiversity of ribonuclease H
por: Pang, Jing, et al.
Publicado: (2022) -
Examining the ribonuclease H primer grip of HIV-1 reverse transcriptase by charge neutralization of RNA/DNA hybrids
por: Dash, Chandravanu, et al.
Publicado: (2008) -
Connection Domain Mutations N348I and A360V in HIV-1 Reverse Transcriptase Enhance Resistance to 3′-Azido-3′-deoxythymidine through Both RNase H-dependent and -independent Mechanisms
por: Ehteshami, Maryam, et al.
Publicado: (2008) -
Mechanism of Ribonuclease III Catalytic Regulation by Serine Phosphorylation
por: Gone, Swapna, et al.
Publicado: (2016)